Answer
Ibrutinib can temporarily move malignant lymphocytes from tissues into the bloodstream. In chronic lymphocytic leukaemia and mantle cell lymphoma, this expected effect does not by itself mean the cancer is worsening.
Sources for this answer
- IMBRUVICA 560 mg film-coated tablets (Great Britain)emc · SmPC Current selected SmPC · Version 15